实现LDL胆固醇目标的挑战和降低脂质的新方法
Waqas A Malick1, Daein Choi1, Anne Langsted2
1Metabolism and Lipids Program, The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
许多患者在动脉样硬化心血管疾病 (ASCVD) 的当前治疗方法中努力达到胆固醇目标. 新型疗法为降低LDL-C和预防心血管事件提供了更持久的解决方案.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 低密度脂蛋白胆固醇 (LDL-C) 是预防动脉样硬化心血管疾病 (ASCVD) 的首要目标.
- 许多高风险患者在使用他类药物治疗时无法达到推的LDL-C目标,导致可预防的事件和增加的医疗费用.
- 对于他类药物治疗的低坚持和对辅助治疗的使用不足,如以谢胺和PCSK9抑制剂,有助于低于最佳的LDL-C管理.
研究的目的:
- 审查与当前降低LDL-C的疗法相关的挑战.
- 讨论实现LDL-C目标和预防ASCVD的新方法的必要性.
- 探索新的实施策略的潜力,以管理与脂蛋白相关的心血管风险.
主要方法:
- 对LDL-C降低疗法的当前文献的综述.
- 分析实现治疗目标所面临的挑战.
- 讨论新的治疗策略,包括inclisiran (siRNA向PCSK9mRNA).
主要成果:
- 目前的治疗方法,包括他类药物,往往无法在高风险患者中达到指南推的LDL-C目标.
- 没有充分利用有效的辅助疗法和多种药物复杂化治疗.
- 新的方法,如向PCSK9mRNA的siRNA,具有更持久的LDL-C降低的潜力.
结论:
- 实现最佳的LDL-C降低仍然是ASCVD预防的重大挑战.
- 新型疗法和实施策略对于改善患者的治疗结果至关重要.
- 创新方法可能为管理脂蛋白相关心血管风险提供更持久和更有效的解决方案.
更多相关视频
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
